Manufacturer of medical devices


BioScience GmbH

ATT – optimized injection properties

CRM - an innovative technology to stabilize hyaluronic acid

Biofermentation – highly tolerable products

„Our commitment to a greater quality of life“

Since 2006 BioScience has been pursuing the development of innovative injectable implants for the optimization of existing treatments and the development of new treatment methods in different medical disciplines. The aim in all areas is to optimize composition, mode of action, and injection behavior in such a way that the recipient's quality of life is improved. In addition to aesthetic medicine, products based on the crosslinking of hyaluronic acid also reveal their positive effects in fields such as urology, gynecology and general surgery. Due to its cross-disciplinary developments and research, BioScience is now one of the world's leading providers of hyaluronic acid gels.